Absorption |
Blood-Brain Barrier | BBB- | 0.9840 |
Human Intestinal Absorption | HIA+ | 0.5462 |
Caco-2 Permeability | Caco2- | 0.7824 |
P-glycoprotein Substrate | Substrate | 0.7570 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6638 |
Non-inhibitor | 0.7247 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9172 |
Distribution |
Subcellular localization | Mitochondria | 0.8288 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6418 |
CYP450 2D6 Substrate | Non-substrate | 0.8823 |
CYP450 3A4 Substrate | Substrate | 0.6668 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8070 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8810 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9044 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8510 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8557 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7147 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9949 |
Non-inhibitor | 0.7534 |
AMES Toxicity | Non AMES toxic | 0.8233 |
Carcinogens | Non-carcinogens | 0.7853 |
Fish Toxicity | High FHMT | 0.9880 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9751 |
Honey Bee Toxicity | Low HBT | 0.6265 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.7157 |
Carcinogenicity (Three-class) | Non-required | 0.6863 |